Search

Author/Creator Warwick-Sanders, Michael

1. 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial. (4th December 2021)

Authors:
Chabria, Shiven; De Wit, Stephane; Pierce, Amy; Shepherd, Bronagh M; Warwick-Sanders, Michael; Du, Fangfang; Wang, Marcia; Clark, Andrew; Ackerman, Peter
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S509
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial. (4th December 2021)

Authors:
Chabria, Shiven; De Wit, Stephane; Pierce, Amy; Shepherd, Bronagh M; Warwick-Sanders, Michael; Du, Fangfang; Wang, Marcia; Clark, Andrew; Ackerman, Peter
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S509
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search